SCHEMBL21889501

SCHEMBL21889501

c1ccc(-c2cc(-c3ccccc3)nc(-c3nc(-n4c5ccccc5c5ccccc54)c(-n4c5ccccc5c5ccccc54)c(-n4c5ccccc5c5ccccc54)c3-n3c4ccccc4c4ccccc43)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.40
KMT2A Q03164 7/20 0.40
HPGD P15428 5/20 0.40
MAPT P10636 5/20 0.40
ALDH1A1 P00352 4/20 0.40
NTSR1 P30989 1/20 0.40
ADORA2A P29274 2/20 0.37
ADORA1 P30542 2/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KDM4E B2RXH2 4/20 0.36
ACHE P22303 1/20 0.36
LMNA P02545 2/20 0.35
GLA P06280 1/20 0.35
MAOA P21397 1/20 0.35
MAOB P27338 1/20 0.35
ATM Q13315 2/20 0.35
AGTR1 P30556 1/20 0.34
TSHR P16473 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21888845 0.95 MEN1 (0.41) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL21888843 0.90 ATM (0.38) MEN1KMT2AADORA2AADORA1L3MBTL1
SCHEMBL21889503 0.89 KDM4E (0.36) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL21889502 0.86 CYP19A1 (0.37) MEN1KMT2AHPGDALDH1A1ADORA2A
SCHEMBL22148790 0.84 KMT2A (0.42) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL23223018 0.84 MEN1 (0.35) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL21888647 0.84 MEN1 (0.41) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL22148792 0.84 MEN1 (0.34) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL21888637 0.83 MEN1 (0.43) MEN1KMT2AHPGDMAPTALDH1A1
SCHEMBL21888646 0.83 MEN1 (0.37) MEN1KMT2AHPGDMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3642303-B1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX INC (JP) 2021-04-14 EP disclosed
US-20200115376-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200115376-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES CRY2, NDUFV3, SLCO1B3 MEN1 3155/4885KMT2A 4167/4885HPGD 2099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.